Effects of Neuromuscular Electrical Stimulation on Critically Ill Patients With Mechanical Ventilation

Sponsor
The Affiliated Hospital of Qingdao University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05217511
Collaborator
(none)
47
1
2
6.9
6.8

Study Details

Study Description

Brief Summary

Up to 25% of patients who require mechanical ventilation (MV) more than seven days in the intensive care unit (ICU) develop muscle weakness, which comprises deep muscle weakness , including the respiratory muscles.Early active mobilization in ICU patients is a safe and viable strategy to prevent the physical problems caused by immobility. Neuromuscular electrical stimulation (NMES) is an alternative to mobilize and exercise because it does not require active patient participation and can be used on bedridden patients.No previous studies have shown whether training-specific respiratory muscles using an electrical stimulation can have overall benefits for ICU patients on MV.For this reason, the aim of this study was to evaluate, the effectiveness of the NMES therapy combined with early rehabilitation in the respiratory muscles of patients on MV.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Neuromuscular Electrical Stimulation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
47 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Neuromuscular Electrical Stimulation on Critically Ill Patients With Mechanical Ventilation
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: NMSE Group

Neuromuscular Electrical Stimulation(NMES) group received consecutive daily sessions of electrical stimulation at specific points starting on the first day of randomization.The subjects also receive conventional physical therapy, which included gross motor therapy and respiratory therapy twice a day every day during their stay in the ICU.

Behavioral: Neuromuscular Electrical Stimulation
NMES was performed using a portable machine.The negative electrodes were placed in the motor points of the following muscles: chest muscles (pectoralis major muscle fibres) and rectus abdominis muscles bilaterally. A second (positive) electrode was positioned distally to the first, at a site close to the muscle that was being electrically stimulated, totalling 1 channel with 2 electrodes for each muscle . Each NMES session lasted 30 min. The following parameters were used: 50 Hz frequency, pulse duration 300 ms, rise time 1 s, stimulus time (ON) 3 s, decay time 1 s, and relaxation time (OFF) 10 s. Intensity was increased until muscle contraction was visible or could be identified through palpation. In conscious patients, intensity was adjusted according to their tolerance.

No Intervention: CPT group

The subjects only receive conventional physical therapy, which included gross motor therapy and respiratory therapy twice a day every day during their stay in the ICU.

Outcome Measures

Primary Outcome Measures

  1. diaphragmatic thickening fraction(DTF) [baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation]

    DTF shows varied thickness of the diaphragm at end-expiration and end-inspiration. Te maximum and minimum values of each breathing cycle were taken as the end-inspiratory diaphragm thickness (DTei) and the end-expiratory diaphragm thickness (DTee), respectively. DTF was calculated by DTF=(DTei DTee)/DTee 100%. Te values for 3 consecutive respiratory cycles were recorded and the average value was taken as the fnal value

Secondary Outcome Measures

  1. Parasternal Intercostal Muscle Ultrasound [baseline,Day 3 of mechanical ventilation,Day 7 of mechanical ventilation,before extubation]

    A 10- to 15-MHz linear array transducer was positioned perpendicular to the anterior thorax surface in the longitudinal scan, at the level of the second right intercostal space, approximately 6 to 8 cm lateral to the sternal edge with a window visualizing the second and third ribs. . Using M-mode, the ultrasound beam was perpendicularly directed at the midsection of the muscle, where it is the thinnest at end-expiration. The thickness of the parasternal intercostal muscle was measured on frozen images at end expiration and at peak inspiration.

Other Outcome Measures

  1. ventilator-free days at 28 days [28 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Prolonged MV(>72 h);

  • Written informed consent was obtained from the patients or their relatives

Exclusion Criteria:
  • Previous neuromuscular disease;

  • Unrelieved pneumothorax, restricted diaphragmatic dyskinesia including abdominal high pressure, a large number of ascites

  • Thoracic or diaphragmatic malformation;

  • Local skin damage and infection;

  • Indwelling a temporary or permanent pacemaker;

  • Severe obesity(BMI>35 kg/m2)

  • Various reasons (severe intestinal gas accumulation, structural abnormalities) lead to the failure of ultrasonic detection of diaphragm movement;

  • Patients with an expected survival time of less than 7 days or with palliative care

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neuromuscular electrical stimulation Qingdao China 266003

Sponsors and Collaborators

  • The Affiliated Hospital of Qingdao University

Investigators

  • Study Director: Jinyan Xing, Dr., The Affiliated Hospital of Qingdao University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
JinyanXing, Director, The Affiliated Hospital of Qingdao University
ClinicalTrials.gov Identifier:
NCT05217511
Other Study ID Numbers:
  • DZH20220104
First Posted:
Feb 1, 2022
Last Update Posted:
Mar 2, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by JinyanXing, Director, The Affiliated Hospital of Qingdao University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2022